6505--Bupropion Tablets 12hr SA Tablets

The solicitation requires offerors to develop a detailed subcontracting plan that justifies each proposed goal, especially when a goal is lower than the VA‑suggested target or lower than the prior year’s achievement. Offerors must describe the specific methods used to identify potential sources (websites, associations, events, etc.) and indicate whether indirect costs are included in the dollar and percentage goals. Separate dollar and percentage subcontracting goals must be provided for each contract period (base and each option), and the plan must be approved under Public Law 95‑507 (FAR 52.219‑9) with either a current commercial plan or a new plan submitted for review. All covered drug products/NDCs must be listed on the offeror’s FSS contract or interim agreement with a permanent FCP by the solicitation due date; non‑compliant offers will be rejected. In addition, contractors must report quarterly sales and remit Cost Recovery Fees in whole‑dollar amounts, hold prices firm for 120 days, and submit required representations and certifications (FAR 52.209‑7, 52.219‑1, 52.212‑3, 52.204‑24, 52.225‑6, etc.) via SAM.gov. The solicitation incorporates numerous FAR provisions (e.g., 52.201‑1, 52.204‑7, 52.204‑16, 52.214‑34/35) and mandates detailed facility information for all pharmaceutical products, including manufacturing, sterilization, packaging, and packing locations. Offerors must also provide quarterly sales reports, product samples (at no cost to the Government), and comply with the program administrator’s reporting requirements, including timely eSRS submissions and plan updates 30 days before expiration.

Notice ID

0568b659e77947fd84153cf8195543de

Solicitation Number

36E79725R0065

NAICS Code

325412

Classification Code

6505